About: Mapping the canine vector-borne disease risk in a Mediterranean area

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Mapping the canine vector-borne disease risk in a Mediterranean area Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Mapping the canine vector-borne disease risk in a Mediterranean area
Creator	Schunack, Bettina Montagnaro, Serena Oliva, Gaetano Boegel, Annette Foglia Manzillo, Valentina Gizzarelli, Manuela Kostopoulou, Despoina Ligda, Panagiota Pollmeier, Matthias Saratsi, Katerina Sotiraki, Smaragda
Source	PMC
abstract	BACKGROUND: The aim of this study was to determine exposure to vector-borne pathogens (VBPs) in populations of dogs living on Greek islands in the Ionian and Aegean seas. METHODS: In total, 1154 dogs with different lifestyles and of varying ages and breeds were randomly sampled and examined for the presence of clinical signs compatible with canine vector-borne diseases (CVBDs). Blood was collected from each individual animal. For the detection of antibodies against Leishmania spp., the WITNESS® Leishmania test was performed, and positive samples were further examined with indirect enzymatic immunoassay (ELISA). Antibodies to Borrelia burgdorferi, Ehrlichia canis or E. ewingii, as well as Anaplasma phagocytophilum or A. platys were investigated using the Snap® 4Dx® Plus test. Positive Ehrlichia spp. and Anaplasma spp. samples were further examined using an indirect ELISA for further identification of the species. RESULTS: In total, 25.6% of dogs were exposed to at least one of the pathogens investigated, with seroprevalences varying regionally. Of these seropositive dogs, 27.4% displayed clinical signs suggestive of CVBDs, such as cutaneous lesions, enlarged lymph nodes, pale mucous membranes, onychogryphosis and weight loss. The overall seroprevalence detected using the rapid tests was 15.3% for Leishmania spp., whereas 2.3% of the examined dogs were found to be positive for Anaplasma spp. and 7.5% for Ehrlichia spp. while B. burgdorferi was not detected. Twenty-four samples positive to A. phagocytophilum by ELISA were analysed by PCR for the presence of Anaplasma DNA. PCR and sequencing results showed the presence of A. platys DNA in 4 samples and E. canis DNA in 4 samples. The remaining samples (66.7%) were negative. CONCLUSIONS: In the present study, exposure of dogs to VBPs was shown in the geographical areas investigated. Results confirm that on Greek islands VBPs represent a constant health risk for both native and visiting dogs, suggesting the presence of distinct “hot-spots” of VBP infections on different islands. In order to reduce the risk of transmission and the spread to non-endemic regions, the protection of dogs through use of repellents and vaccines, together with owner education, seem to be of paramount importance. [Image: see text]
has issue date	2020-06-03(xsd:dateTime)
bibo:doi	10.1186/s13071-020-04153-8
has license	cc-by
sha1sum (hex)	2fa8f1a06b31670cd2dc46da38cbaf0c7845f7e1
schema:url	https://doi.org/10.1186/s13071-020-04153-8
resource representing a document's title	Mapping the canine vector-borne disease risk in a Mediterranean area
has PubMed Central identifier	PMC7268178
schema:publication	Parasit Vectors
resource representing a document's body	covid:2fa8f1a06b31670cd2dc46da38cbaf0c7845f7e1#body_text
is schema:about of	named entity 'dogs' covid:arg/2fa8f1a06b31670cd2dc46da38cbaf0c7845f7e1 named entity 'aim' named entity 'Aegean' named entity 'Mediterranean' named entity 'animal health' named entity 'vectorborne' named entity 'Paxoi' named entity 'IDEXX Laboratories' named entity 'South Aegean' named entity 'vector-borne diseases' named entity 'serological testing' named entity 'Borrelia' named entity 'Leros' named entity 'Anaplasma phagocytophilum' named entity 'antibodies' named entity 'clinical signs' named entity 'pathogen' named entity 'Anaplasma' named entity 'precipitation' named entity 'health risk' named entity 'arthropods' named entity 'NESS' named entity 'Zoetis' named entity 'cutaneous' named entity 'antibodies' named entity 'Paxoi' named entity 'Zakinthos' named entity 'Crete' named entity 'Anaplasma' named entity 'Rhipicephalus' named entity 'sand fly' named entity 'Zoetis' named entity 'L. tropica' named entity 'weight loss' named entity 'Leishmania infantum' named entity 'pathogens' named entity 'Qiagen' named entity 'pathogenesis' named entity 'mucous membranes' named entity 'Greece' named entity 'precipitation' named entity 'seropositive' named entity 'study population' named entity 'Zakinthos' named entity 'Anaplasma' named entity 'South Aegean' named entity 'Anaplasma' named entity 'pathogen' named entity 'epidemiology' named entity 'seroprevalence' named entity 'Ehrlichia' named entity 'Zakinthos' named entity 'Greece' named entity 'antibodies' named entity 'Aegean islands' named entity 'Crete' named entity 'arthropods' named entity 'health risk' named entity 'mosquitoes' named entity 'Neorickettsia sennetsu' named entity 'climatic conditions' named entity 'R. sanguineus' named entity 'deciduous trees' named entity 'immunoassay' named entity 'spp' named entity 'Leros' named entity 'Germany' named entity 'Wolbachia' named entity 'cutaneous leishmaniasis' named entity 'canine' named entity 'E. canis' named entity 'Leishmania'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software